We are live on
!
Find out more
Flossbach Von Storch Portfolio holdings
AUM
$21.4B
1-Year Est. Return
8.31%
This Fund
S&P 500
This Quarter
Est. Return
-2.3%
1 Year Est. Return
+8.31%
3 Year Est. Return
+45.09%
5 Year Est. Return
+32.11%
10 Year Est. Return
+160.13%
AUM
$5.82B
AUM Growth
-$462M
(-7.3%)
Cap. Flow
-$418M
Cap. Flow
% of AUM
-7.18%
Top 10 Holdings %
Top 10 Hldgs %
64.24%
Holding
100
New
6
Increased
21
Reduced
37
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$196M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$108M |
| 3 |
Bath & Body Works
BBWI
|
+$99.1M |
| 4 |
Microsoft
MSFT
|
+$81.9M |
| 5 |
Capri Holdings
CPRI
|
+$64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$220M |
| 2 |
Emerson Electric
EMR
|
+$137M |
| 3 |
IBM
IBM
|
+$123M |
| 4 |
Philip Morris
PM
|
+$120M |
| 5 |
Procter & Gamble
PG
|
+$95.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.23% |
| 2 | Technology | 18.36% |
| 3 | Financials | 16.73% |
| 4 | Consumer Discretionary | 14.34% |
| 5 | Consumer Staples | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Abbott
ABT
$187B
| $571M | 9.8% |
14,514,773
+4,936,655
| +52% | +$196M |
|
2
Apple
AAPL
$4.99T
| $518M | 8.9% |
21,684,484
+1,823,320
| +9% | +$45.3M |
|
3
Berkshire Hathaway Class B
BRK.B
$1.11T
| $502M | 8.63% |
3,467,559
+103,417
| +3% | +$14.8M |
|
|
4
Capri Holdings
CPRI
$1.88B
| $453M | 7.78% |
9,155,014
+1,303,589
| +17% | +$64M |
|
|
5
Microsoft
MSFT
$2.92T
| $362M | 6.22% |
7,070,342
+1,576,617
| +29% | +$81.9M |
|
6
Johnson & Johnson
JNJ
$643B
| $329M | 5.66% |
2,715,730
-514,495
| -16% | -$58.5M |
|
7
Coca-Cola
KO
$380B
| $277M | 4.77% |
6,120,620
+197,680
| +3% | +$8.93M |
|
8
Mastercard
MA
$497B
| $254M | 4.37% |
2,886,590
+292,540
| +11% | +$27.9M |
|
|
9
Alphabet (Google) Class A
GOOGL
$4.08T
| $241M | 4.15% |
6,858,540
+2,931,500
| +75% | +$108M |
|
10
Danaher
DHR
$140B
| $231M | 3.96% |
3,398,323
-660,874
| -16% | -$43.2M |
|
|
11
Procter & Gamble
PG
$347B
| $212M | 3.63% |
2,498,156
-1,165,490
| -32% | -$95.7M |
|
12
Amgen
AMGN
$212B
| $192M | 3.3% |
1,263,342
+83,610
| +7% | +$13M |
|
13
RTX Corp
RTX
$295B
| $178M | 3.06% |
2,758,504
-136,606
| -5% | -$8.74M |
|
14
Medtronic
MDT
$111B
| $138M | 2.37% |
1,587,051
-288,939
| -15% | -$23.4M |
|
15
Visa
V
$697B
| $128M | 2.19% |
1,720,771
+377,281
| +28% | +$29.5M |
|
16
Booking.com
BKNG
$154B
| $123M | 2.12% |
2,468,425
-807,200
| -25% | -$41.9M |
|
17
3M
MMM
$94.1B
| $115M | 1.97% |
784,543
-183,483
| -19% | -$25.9M |
|
|
18
Bath & Body Works
BBWI
$4.13B
| $113M | 1.95% |
2,086,354
+1,691,350
| +428% | +$99.1M |
|
|
19
IBM
IBM
$214B
| $112M | 1.93% |
772,993
-858,223
| -53% | -$123M |
|
20
TJX Companies
TJX
$178B
| $85.8M | 1.47% |
2,221,710
+403,560
| +22% | +$15.4M |
|
21
PayPal
PYPL
$50.3B
| $65.5M | 1.13% |
1,794,990
+127,260
| +8% | +$4.87M |
|
22
Baidu
BIDU
$35.6B
| $50.5M | 0.87% |
305,600
+104,665
| +52% | +$18.4M |
|
23
Newmont
NEM
$96.4B
| $42.6M | 0.73% |
1,089,110
-6,230
| -0.6% | -$206K |
|
24
Union Pacific
UNP
$175B
| $42.5M | 0.73% |
487,558
-58,592
| -11% | -$4.95M |
|
25
Ametek
AME
$55.3B
| $42.2M | 0.73% |
912,900
+438,700
| +93% | +$21.1M |
|
Similar funds
IC
AA
MMH
DSA
VARA
SC
CB
Flossbach Von Storch's Q2 2016 Portfolio in Review
As of Q2 2016, Flossbach Von Storch held 100 positions worth $5.82B, down 7.3% from $6.28B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Flossbach Von Storch withdrew a net $418M in Q2 2016, closing 8 positions and reducing 37 holdings. Its most notable exit was Pfizer, an estimated $33.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
Against the trend, Flossbach Von Storch opened a new position in Roper Technologies worth $1.19M.
- Flossbach Von Storch's largest Q2 2016 buy was Roper Technologies: 7,000 shares worth $1.19M.
- Flossbach Von Storch added most to Abbott in Q2 2016, an estimated $196M increase.
- Flossbach Von Storch's biggest Q2 2016 reduction was Qualcomm, cutting an estimated $220M.
- Flossbach Von Storch fully exited Pfizer in Q2 2016, selling an estimated $33.7M.
- Flossbach Von Storch's ten largest holdings make up 64% of its $5.82B portfolio in Q2 2016.
- Flossbach Von Storch opened 6 new positions and closed 8 in Q2 2016.
- Flossbach Von Storch's portfolio value fell 7.3% quarter-over-quarter to $5.82B.
Based on Flossbach Von Storch's 13F filing for Q2 2016, filed 28 Jul 2016.